We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Nuclear Medicine Set for Continued Growth Driven by Demand for Precision Diagnostics

By HospiMedica International staff writers
Posted on 03 Feb 2026

Clinical imaging services face rising demand for precise molecular diagnostics and targeted radiopharmaceutical therapy as cancer and chronic disease rates climb. More...

A new market analysis projects rapid expansion of nuclear medicine, indicating how modalities, end users, and regions are likely to drive growth through 2030.

The analysis by MarketsandMarkets forecasts the nuclear medicine market to grow from USD 10.41 billion in 2025 to USD 21.01 billion by 2030, representing a 15.1% compound annual growth rate. Diagnostic nuclear medicine held a larger share than therapeutic applications in 2024, reflecting widespread use of positron emission tomography (PET) and single-photon emission computed tomography (SPECT) for noninvasive detection and longitudinal monitoring. Continued radiotracer innovation and imaging system advancements are cited as contributors to diagnostic utility.

Adoption is being propelled by the need for accurate disease characterization in oncology, cardiology, and neurology. Expanding theranostic approaches and the introduction of novel radioisotopes are moving the field toward more personalized, targeted care. Improvements such as digital PET, AI-based image analysis, and automated dose dispensing are described as enhancing diagnostic precision and operational efficiency.

Hospitals are projected to be the fastest-growing end user segment. Investment in advanced imaging suites, development of in-house nuclear medicine capabilities, and expansion of hospital radiopharmacies are highlighted as drivers. Integrated diagnostic services that streamline workflow and support multidisciplinary decision-making are expected to reinforce this trajectory.

North America is projected to lead regional growth. The region’s established radiopharmaceutical manufacturing and distribution networks, strong healthcare infrastructure, wide access to nuclear medicine services, and an active regulatory environment supporting new tracers and indications are identified as key factors. 

Related Links
MarketsandMarkets


Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Blood Pressure Monitor
Cuff Blood Pressure Monitor
Surgical Dressing
ALLEVYN Ag+ SURGICAL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Design-science framework integrating CML and LLM pipelines for supply chain risk evaluation. (Gupta I, Konduru H, Correa S, et al. A causal analytics approach for interpretable supply chain risk and supplier performance evaluation. Supply Chain Analytics, 2026. doi:10.1016/j.sca.2026.100248)

Causal AI Tool Withholds Ovarian Cancer Treatment Recommendations When Evidence Insufficient

Ovarian cancer treatment often requires individualized decisions, particularly when available patient data do not clearly favor one therapeutic approach. However, artificial intelligence (AI) systems may... Read more

Patient Care

view channel
Image: A view inside the custom virtual reality environment used in the study: a calm room with a teddy bear, soft colors and large windows looking out over the sea. (Image Credit: Walaa S. Abu Rukbah et al., Virginia Commonwealth University; CC-BY 4.0, https://creativecommons.org/licenses/by/4.0/)

Virtual Reality Program May Reduce Anxiety Before Pediatric Surgery

Presurgery anxiety affects an estimated 50% to 75% of children undergoing surgery and can complicate anesthesia induction, increase postoperative pain, and prolong recovery. Sedation is often used to manage... Read more

Point of Care

view channel
Image: Jessica Ramella-Roman, professor of biomedical engineering at Florida International University, holding the PPRIM (Portable Preterm Imaging) device designed to detect early signs of preterm labor risk. (Photo courtesy of Florida International University)

Handheld Imaging Device May Help Identify Preterm Birth Risk Earlier

Preterm birth, defined as delivery before 37 weeks of pregnancy, can lead to serious neonatal complications, including neurological, developmental, and respiratory problems. However, identifying pregnancies... Read more

Business

view channel
Image: Stryker has acquired ZuriMED, adding the FiberLocker System, a rotator cuff augmentation technology designed to strengthen repairs, to its Sports Medicine portfolio. (Photo courtesy of ZuriMED)

Stryker Completes Acquisition to Broaden Shoulder Surgery Offerings

Stryker (Portage, MI, USA) has completed its acquisition of ZuriMED (Zurich, Switzerland), a privately held developer of the FiberLocker System, expanding its Sports Medicine portfolio with a commercialized... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.